Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galectin Therapeutic (NQ: GALT )

2.310 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,228
Open 2.350
Bid (Size) 2.100 (1)
Ask (Size) 2.550 (9)
Prev. Close 2.310
Today's Range 2.250 - 2.400
52wk Range 1.555 - 4.268
Shares Outstanding 59,395,805
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Via Benzinga

Performance

YTD
+32.76%
+32.76%
1 Month
-9.41%
-9.41%
3 Month
-18.09%
-18.09%
6 Month
+22.87%
+22.87%
1 Year
+39.77%
+39.77%

More News

Read More
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
Via InvestorPlace
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
Via InvestorPlace
Galectin Therapeutics: Q3 Earnings Insights
Via Benzinga
Recap: Galectin Therapeutics Q1 Earnings
Via Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Via The Motley Fool
More Personal Portfolio: Biotech, Commodities, And Gold
Via Talk Markets
Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
7 Short-Interest Stocks to Target for Explosive Gains
Via InvestorPlace
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Around $30 Million Bet On This Communication Services Stock? 4 Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Via Benzinga
62 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Galectin Therapeutics: Q4 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.